FDA
- Marketing authorisation holder: LILLY
- Status: approved
🇺🇸 Moxam in United States
Moxam (latamoxef) regulatory status in United States.
Marketing authorisations
FDA
- Application: NDA050550
- Marketing authorisation holder: LILLY
- Local brand name: MOXAM
- Indication: INJECTABLE — INJECTION
- Status: approved
Moxam in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Moxam approved in United States?
Yes. FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Moxam in United States?
LILLY holds the US marketing authorisation.